234 related articles for article (PubMed ID: 31539917)
21. Melanogenesis stimulation in murine B16 melanoma cells by Kava (Piper methysticum) rhizome extract and kavalactones.
Matsuda H; Hirata N; Kawaguchi Y; Naruto S; Takata T; Oyama M; Iinuma M; Kubo M
Biol Pharm Bull; 2006 Apr; 29(4):834-7. PubMed ID: 16595931
[TBL] [Abstract][Full Text] [Related]
22. Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.
Li Y; Mei H; Wu Q; Zhang S; Fang JL; Shi L; Guo L
Toxicol Sci; 2011 Dec; 124(2):388-99. PubMed ID: 21908763
[TBL] [Abstract][Full Text] [Related]
23. Fourier transform ion cyclotron resonance mass spectrometry for the characterisation of kavalactones in the kava plant: elemental formulae confirmation by dual spray accurate mass measurement and structural confirmation by infrared multiphoton dissociation and sustained off-resonance irradiation collision induced dissociation.
Warburton E; Bristow T
Eur J Mass Spectrom (Chichester); 2006; 12(4):223-33. PubMed ID: 17057279
[TBL] [Abstract][Full Text] [Related]
24. Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors.
Oh JM; Rangarajan TM; Chaudhary R; Singh RP; Singh M; Singh RP; Tondo AR; Gambacorta N; Nicolotti O; Mathew B; Kim H
Molecules; 2020 May; 25(10):. PubMed ID: 32443652
[TBL] [Abstract][Full Text] [Related]
25. Investigation of pyrazolo[1,5-a]quinoxalin-4-ones as novel monoamine oxidase inhibitors.
Panova VA; Filimonov SI; Chirkova ZV; Kabanova MV; Shetnev AA; Korsakov MK; Petzer A; Petzer JP; Suponitsky KY
Bioorg Chem; 2021 Mar; 108():104563. PubMed ID: 33376014
[TBL] [Abstract][Full Text] [Related]
26. Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens.
Lee HW; Ryu HW; Kang MG; Park D; Oh SR; Kim H
Bioorg Med Chem Lett; 2016 Oct; 26(19):4714-4719. PubMed ID: 27575476
[TBL] [Abstract][Full Text] [Related]
27. Electrospray high performance liquid chromatography-mass spectrometry in phytochemical analysis of kava (Piper methysticum) extract.
He XG; Lin LZ; Lian LZ
Planta Med; 1997 Feb; 63(1):70-4. PubMed ID: 17252331
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of brain mitochondrial monoamine oxidases by the endogenous compound 5-hydroxyoxindole.
Crumeyrolle-Arias M; Tournaire MC; Cane A; Launay JM; Barritault D; Medvedev A
Biochem Pharmacol; 2004 Mar; 67(5):977-9. PubMed ID: 15104251
[TBL] [Abstract][Full Text] [Related]
29. Coumarin derivatives as inhibitors of d-amino acid oxidase and monoamine oxidase.
Bester E; Petzer A; Petzer JP
Bioorg Chem; 2022 Jun; 123():105791. PubMed ID: 35413582
[TBL] [Abstract][Full Text] [Related]
30. Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
Lefin R; Petzer A; Petzer JP
Bioorg Med Chem; 2022 Jan; 54():116558. PubMed ID: 34915314
[TBL] [Abstract][Full Text] [Related]
31. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
Engelbrecht I; Petzer JP; Petzer A
Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of human cytochrome P450 activities by kava extract and kavalactones.
Mathews JM; Etheridge AS; Black SR
Drug Metab Dispos; 2002 Nov; 30(11):1153-7. PubMed ID: 12386118
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues.
Strydom B; Malan SF; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2010 Feb; 18(3):1018-28. PubMed ID: 20093036
[TBL] [Abstract][Full Text] [Related]
34. Analysis of kavalactones from Piper methysticum (kava-kava).
Bilia AR; Scalise L; Bergonzi MC; Vincieri FF
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 812(1-2):203-14. PubMed ID: 15556499
[TBL] [Abstract][Full Text] [Related]
35. Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism.
Chua HC; Christensen ET; Hoestgaard-Jensen K; Hartiadi LY; Ramzan I; Jensen AA; Absalom NL; Chebib M
PLoS One; 2016; 11(6):e0157700. PubMed ID: 27332705
[TBL] [Abstract][Full Text] [Related]
36. Monoamine oxidase inhibitory components from Cayratia japonica.
Han XH; Hong SS; Hwang JS; Lee MK; Hwang BY; Ro JS
Arch Pharm Res; 2007 Jan; 30(1):13-7. PubMed ID: 17328236
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and Evaluation of 2-benzylidene-1-tetralone Derivatives for Monoamine Oxidase Inhibitory Activity.
Amakali KT; Legoabe LJ; Petzer A; Petzer JP
Cent Nerv Syst Agents Med Chem; 2018; 18(2):136-149. PubMed ID: 29714148
[TBL] [Abstract][Full Text] [Related]
38. Quinolinyl-thienyl chalcones as monoamine oxidase inhibitors and their in silico modeling studies.
Zaib S; Rizvi SU; Aslam S; Ahmad M; Ali Abid SM; Al-Rashida M; Iqbal J
Med Chem; 2015; 11(6):580-9. PubMed ID: 25541744
[TBL] [Abstract][Full Text] [Related]
39. The inhibition of monoamine oxidase by phenformin and pentamidine.
Barkhuizen M; Petzer A; Petzer JP
Drug Res (Stuttg); 2014 Sep; 64(9):454-61. PubMed ID: 24307270
[TBL] [Abstract][Full Text] [Related]
40.
Krum BN; de Freitas CM; Busanello A; Schaffer LF; Fachinetto R
J Tradit Complement Med; 2022 Mar; 12(2):115-122. PubMed ID: 35528470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]